intracellular s aureus s aureus intracellular what does
play

intracellular S. aureus S. aureus : : intracellular what does it - PowerPoint PPT Presentation

intracellular S. aureus S. aureus : : intracellular what does it mean ? what does it mean ? F. Van Bambeke F. Van Bambeke Unit de Pharmacologie cellulaire et molculaire Unit de Pharmacologie cellulaire et molculaire Universit


  1. intracellular S. aureus S. aureus : : intracellular what does it mean ? what does it mean ? F. Van Bambeke F. Van Bambeke Unité de Pharmacologie cellulaire et moléculaire Unité de Pharmacologie cellulaire et moléculaire Université catholique de Louvain Université catholique de Louvain Brussels, Belgium Brussels, Belgium GSK-chair of infectious diseases

  2. Intracellular killing of bacteria by host cell defense mechanisms Phagosomes Lysosomes Phagolysosomes

  3. Some bacteria can escape host cell defense mechanisms Carryn et al , Infect Dis Clin North Am. (2003) 17:615-34 Early endosomes Phagosomes Phagosomes Inclusions Mycobacterium spp. Chlamydia spp. Salmonella spp. Brucella spp. Lysosomes Cytosol Listeria monocytogenes Shigella flexeneri Endoplasmic reticulum Phagolysosomes Legionella pneumophila Legionella pneumophila Staphylococcus aureus opportunistic intracellular bacteria

  4. Evidence for intracellular S. aureus in vitro and in vivo – model of mastitis phagocytic cells non phagocytic PMN, cells macrophages Brouillette et al , Vet Microbiol (2004) 101:253-262; Microb Pathog. (2003) 35:159-68.

  5. Intracellular cycle of S. aureus cytotoxicity and adhesion internalisation cellular response FnBP cytokines fibronectin β -integrin actin polymerisation escape In the cytosol apoptosis of host cell Lowy, Trends Microbiol (2000) 8:341-342

  6. Intracellular survival of S. aureus cytotoxicity and adhesion internalisation cellular response FnBP cytokines fibronectin β -integrin actin polymerisation Lowy, Trends Microbiol (2000) 8:341-342

  7. In vivo implication remains however a matter of debate Clearly established in in vitro models Few reports in vivo � low density of intracellular foci � destructive nature of S. aureus infection � multiple mechanisms of adherence and invasion

  8. S. aureus can survive and multiply in phagocytes and several other cell types

  9. But is this associated with pathology ? osteoblasts keratinocytes endothelial cells epithelial cells

  10. In vivo implication remains however a matter of debate Clearly established in in vitro models Few reports in vivo � low density of intracellular foci � destructive nature of S. aureus infection � multiple mechanisms of adherence and invasion Useful to study to understand pathogenesis and explore therapeutic options

  11. Setting up a model of intracellular infection over a 24 h period of time 5 h infection no antibiotic gentamicin 0.5 mg/L • infection of macrophages (with opsonized bacteria) • Mouse (J774; 5 bact/cell) • Human (THP-1; 4 bact/cell) • washing with GEN 50 µg/ml to eliminate extracellular bacteria • incubation for up to 24 h with � GEN 0.5 µg/ml (MIC) � antibiotic under study Seral et al. AAC 2003 47:2283-2292

  12. Description of the model : how does S. aureus grow intracellularly ? extra 4 intra from time 0 h ∆ log CFU 2 0 0 6 12 18 24 time (h) Seral et al. AAC 2003 47:2283-2292

  13. intracellular vs extracellular activity of antibiotics : is it easily predictible ? Intracellular activity = MIC. X accumulation

  14. intracellular vs extracellular activity of antibiotics : PK – PD in action Carryn et al , Infect Dis Clin North Am. (2003) 17:615-34

  15. Intracellular killing is visible for antibiotics control working on cell wall oxacillin oritavancin

  16. Smart choice of antibiotics based on balanced extra- / intra- activity

  17. Intracellular activity : possible reasons for loss of activity AB Cc/Ce Max. activity OXA < 4 -1.6 GEN 4 -2.5 MXF 8 -2.8 AZM 38 -0.2 Drug (lysosomal) ORI 148 -3.2 accumulation

  18. Intracellular activity : possible reasons for loss of activity AB MIC pH 7.4 pH 5.4 AZM 0.5 512 GEN 0.5 16 MXF 0.06 0.25 Lysosomal ORI 0.25 0.25 acidic pH OXA 0.125 0.06

  19. Intracellular activity : possible reasons for loss of activity macrophages exposed to oritavancin bioavailability

  20. Intracellular activity : possible reasons for loss of activity Rapid equilibration by diffusion quinolones beta-lactams access to the infected compartment slow accumulation by endocytosis aminoglycosides glycopeptides

  21. Intracellular activity : possible reasons for loss of activity slow growth extra 4 intra from time 0 h ∆ log CFU 2 0 0 6 12 18 24 time (h) metabolic changes involved in Bacterial responsiveness invasion and toxicity

  22. Take home message

  23. Thanks to … Maritza Maritza Cristina Cristina Barcia- -Macay Macay Barcia Seral Seral Sandrine Sandrine Paul M. Paul M. Marie- Marie -Paule Paule Lemaire Lemaire Tulkens Tulkens Mingeot- -Leclercq Leclercq Mingeot

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend